| Trial ID: | L7073 |
| Source ID: | NCT01217905
|
| Associated Drug: |
Azd7687
|
| Title: |
Japanese Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic (PK) & Pharmacodynamic (PD) Study of AZD7687
|
| Acronym: |
JSMAD
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Obesity
|
| Interventions: |
DRUG: AZD7687
|
| Outcome Measures: |
Primary: Investigate the safety and tolerability of AZD7687 following administration of single and multiple doses, From screening period to follow-up visit 45 days (Maximum). | Secondary: Evaluate the pharmacokinetics (PK) (plasma and urine) of AZD7687 and it´s glucuronic acid metabolite (AZ13128940) after single and multiple doses, Before dose and repeatedly to follow-up visit
|
| Sponsor/Collaborators: |
Sponsor: AstraZeneca
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2010-11
|
| Completion Date: |
2011-07
|
| Results First Posted: |
|
| Last Update Posted: |
2012-02-13
|
| Locations: |
Research site, Croydon, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT01217905
|
